Cell-based therapies, which all involve processes for procurement and reimplantation of living cells, currently rely upon expensive, inconsistent, and even toxic enzyme digestion processes. A prime example is the preparation of isolated pancreatic islets for the treatment of type 1 diabetes by transplantation. To avoid the inherent pitfalls of these enzymatic methods, we have conceptualized an alternative approach based on the hypothesis that cryobiological techniques can be used for differential freeze destruction of the pancreas (Px) to release islets that are selectively cryopreserved in situ. Pancreata were procured from juvenile pigs using approved procedures. The concept of cryoisolation is based on differential processing of the pancreas in five stages: 1) infiltrating islets in situ preferentially with a cryoprotectant (CPA) cocktail via antegrade perfusion of the major arteries; 2) retrograde ductal infusion of water to distend the acinar; 3) freezing the entire Px solid to < -160°C for storage in liquid nitrogen; 4) mechanically crushing and pulverizing the frozen Px into small fragments; 5) thawing the frozen fragments, filtering, and washing to remove the CPA. Finally, the filtered effluent (cryoisolate) was stained with dithizone for identification of intact islets and with Syto 13/PI for fluorescence viability testing and glucose-stimulated insulin release assessment. As predicted, the cryoisolate contained small fragments of residual tissue comprising an amorphous mass of acinar tissue with largely intact and viable (>90%) embedded islets. Islets were typically larger (range 50-500 µm diameter) than their counterparts isolated from juvenile pigs using conventional enzyme digestion techniques. Functionally, the islets from replicate cryoisolates responded to a glucose challenge with a mean stimulation index = 3.3 ± 0.7. An enzyme-free method of islet isolation relying on in situ cryopreservation of islets with simultaneous freeze destruction of acinar tissue is feasible and proposed as a new and novel method that avoids the problems associated with conventional collagenase digestion methods.

译文

基于细胞的疗法都涉及活细胞的采购和再植过程,目前依赖于昂贵,不一致甚至有毒的酶消化过程。一个典型的例子是通过移植制备用于治疗1型糖尿病的孤立胰岛。为了避免这些酶方法固有的缺陷,我们基于以下假设概念化了另一种方法: 低温生物学技术可用于胰腺 (Px) 的不同冷冻破坏,以释放选择性原位冷冻保存的胰岛。使用批准的程序从幼猪中采购胰腺。冷冻隔离的概念基于胰腺在五个阶段的差异处理: 1) 通过主要动脉的顺行灌注,优先用冷冻保护剂 (CPA) 鸡尾酒原位浸润胰岛; 2) 逆行导管注入水以扩大腺泡; 3) 将整个Px固体冷冻至 < -160 ℃,以便在液氮中储存; 4) 将冷冻的Px机械粉碎并粉碎成小碎片; 5) 将冷冻的碎片解冻,过滤,洗涤以去除CPA。最后,将过滤后的流出物 (冷冻分离物) 用双硫zone染色以鉴定完整的胰岛,并用sy向13/PI染色以进行荧光活力测试和葡萄糖刺激的胰岛素释放评估。如所预测的,冷冻分离物包含残余组织的小片段,所述残余组织包含具有基本完整和存活 (>90%) 嵌入的胰岛的无定形物质的腺泡组织。胰岛通常比使用常规酶消化技术从幼猪中分离出的胰岛更大 (直径为50-500 µ m)。从功能上讲,来自复制冷冻分离株的胰岛以平均刺激指数   =   3.3   ±   0.7响应葡萄糖挑战。依靠原位冷冻保存胰岛并同时冻结腺泡组织的无酶胰岛隔离方法是可行的,并被提出为一种新的新颖方法,可避免与常规胶原酶消化方法有关的问题。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录